Clinical Trial Update: Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance

View source ↗

Summary

An ongoing clinical trial investigating the response to semaglutide in non-diabetic obese adults with differing levels of insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

Sponsor: ETH Zurich | Conditions: Obesity and Obesity-related Medical Conditions, Obesity and Overweight | Status: RECRUITING